Hearscape
← Companies
Company

Phafag AG

Company-level hearing-loss landscape profile across checked programs, evidence quality, modalities, indications, and open data checks.

All ProgramsTherapeuticsDevices
Open filtered programs
Programs
1
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
1
0 open data checks
Company / Institution Links
1 / 0
industry vs non-industry records
Competitive Density
3
Pipeline Velocity
30
Completion Signal
100

Programs by Stage

Phase 31

Trial / Program Status

Paused1

Modality Mix

Small Molecule1

Indication Coverage

Age-Related Hearing Loss1
Hearing Loss1
Sudden Hearing Loss1
Tinnitus1

Program Types

Therapeutic1

Population Tags

adult1
inner-ear-disease1
older-adult1
tinnitus1

Strong-Evidence Records

0 records
No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks
Transtympanic caroverine by Phafag
Details checked
Small MoleculePhase 3Paused

Transtympanic caroverine solution evaluated for tinnitus associated with inner-ear disease; caroverine is a small-molecule quinoxalinone reported in public compound sources as caroverine/caroverin.

Data checks: registry-only-current-status, no-public-results-confirmed